Overview

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

Status:
RECRUITING
Trial end date:
2025-09-15
Target enrollment:
Participant gender:
Summary
Purpose: The study aims to investigate how Filgotinib affects proteins and micro-RNA in the blood of patients with rheumatoid arthritis. This could help understand its impact on inflammation and bone health in these patients. Study Design: This is a single-center, prospective randomized study.
Phase:
PHASE4
Details
Lead Sponsor:
Universita di Verona
Treatments:
Adalimumab
GLPG0634